Biotech News
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
bioAffinity Technologies, Inc. (BIAF)bioAffinity Technologies, Inc.2026-06-25 13:46 ESTCompany update
BIAF (BIAF) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.
The source domain is biaf.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.
The original release is available below in a new tab so readers can continue into the full source when needed.